PRPH Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -0.89% compare to its pairs and should correct downwards.

Stats
Šios dienos apimtis	36 911
Vidutinė apimtis	60 653
Rinkos kapitalizacija	79.75M
EPS	$-0.350 ( Q1 \| 2024-05-10 )
Kita pelno data	( $-0.250 ) 2024-08-08
Last Dividend	$0.300 ( 2022-05-24 )
Next Dividend	$0 ( N/A )
P/E	-3.07 (Sector) 42.63 (Industry) 0
ATR14	$0.0150 (0.36%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX -1.40%

AKAN -3.75%

ALIM 0.54%

AMPH -0.87%

AMYT 0.00%

ANIP 0.94%

AQST 0.39%

ASRT -5.34%

ATNX 0.00%

AVDL -1.75%

AYTU 0.00%

BFRI -2.39%

BGXX -34.22%

CLVR -2.22%

COLL -0.74%

CPIX 0.66%

CRDL 1.00%

CRON -0.43%

CYTH 5.83%

DCPH 0.00%

DERM 9.73%

DRRX -5.49%

DVAX -1.23%

EGRX 11.55%

EMBC 0.32%

EMBCV -9.33%

EOLS -0.73%

ESPR -3.90%

EVOK 5.48%

FLGC 6.71%

FLXN 0.00%

GHSI -0.35%

HCM -1.83%

HROW -0.52%

HUGE -4.71%

IMCC 2.20%

INCR 2.03%

IRWD 5.16%

ITCI -3.51%

IXHL 10.53%

JUPW 11.76%

KALA 9.92%

KIN 0.11%

KMDA -1.78%

LNTH -1.25%

NBIX 2.50%

NEPT 0.00%

NLTX 1.45%

OGI -3.75%

OPTN -3.70%

ORGO 6.06%

PAHC -2.50%

PCRX 2.51%

PETQ -0.45%

PLXP 0.00%

PPD 0.00%

PROC -0.40%

PRPH -2.11%

PTPI 2.69%

RDHL -2.58%

RDUS 4.30%

REPH -0.48%

RGC -5.88%

RMTI 0.00%

SCTL 0.92%

SCYX -1.48%

SIGA 3.13%

SISI -13.33%

SNDL -1.04%

SNOA 1.05%

SSIC 1.03%

SUPN -0.45%

SXTC -2.24%

THTX 0.00%

TKNO -1.44%

TLGT -13.85%

TLRY -4.05%

TXMD -7.47%

TYHT -3.90%

UPC -1.97%

VTRS 1.43%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2024-03-17	Karkus Ted William	Buy	400 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	500 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	0
2024-03-17	Hirsch Warren	Buy	70 000	Option (right to buy)
2024-03-17	Gleckel Louis Md	Buy	70 000	Option (right to buy)

INSIDER POWER
22.44
Last 98 transactions
Buy: 8 777 863 \| Sell: 8 858 292

Koreliacija (AI algo v.1.1b): Overvalued: -0.89% $4.19 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.22 (neutral)

Trumpas: 0.98 (very strong)

Signal:(56.692) Expect same movement, but be aware

Prophase Labs Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
CLRO	0.843
LTRN	0.834

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Prophase Labs Inc Koreliacija - Valiuta/Žaliavos

-0.76
( moderate negative )

-0.50
( neutral )

0.00
( neutral )

-0.67
( moderate negative )

0.00
( neutral )

-0.28
( neutral )

Prophase Labs Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$44.38M
Bruto pelnas:	$16.24M (36.59 %)
EPS:	$-0.980

FY	2023
Pajamos:	$44.38M
Bruto pelnas:	$16.24M (36.59 %)
EPS:	$-0.980

FY	2022
Pajamos:	$122.65M
Bruto pelnas:	$70.65M (57.61 %)
EPS:	$1.170

FY	2021
Pajamos:	$79.04M
Bruto pelnas:	$41.99M (53.12 %)
EPS:	$0.540

Financial Reports:

No articles found.

Prophase Labs Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Prophase Labs Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$1.000	2018-06-06
Last Dividend	$0.300	2022-05-24
Next Dividend	$0	N/A
Payout Date	2022-06-03
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$2.40	--
Avg. Dividend % Per Year	2.00%	--
Score	1.36	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-11-07)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2018	$1.000	44.60%
2019	$0.500	15.40%
2020	$0	0.00%
2021	$0.300	2.84%
2022	$0.600	8.10%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
24 May 2022	$0.300	13 May 2022	25 May 2022	03 Jun 2022
28 Feb 2022	$0.300	16 Feb 2022	01 Mar 2022	10 Mar 2022
24 May 2021	$0.300	13 May 2021	25 May 2021	03 Jun 2021
02 Dec 2019	$0.250	20 Nov 2019	03 Dec 2019	12 Dec 2019
09 Jan 2019	$0.250	26 Dec 2018	10 Jan 2019	24 Jan 2019
06 Jun 2018	$1.000	08 May 2018	21 May 2018	05 Jun 2018

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.822	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.262	1.200	-8.74	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.450	1.500	-6.11	-9.16	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.884	0.800	5.58	4.46	[1 - 3]
quickRatioTTM	1.544	0.800	5.62	4.50	[0.8 - 2.5]
cashRatioTTM	0.0726	1.500	-0.708	-1.062	[0.2 - 2]
debtRatioTTM	0.172	-1.500	7.14	-10.00	[0 - 0.6]
interestCoverageTTM	-19.55	1.000	-8.35	-8.35	[3 - 30]
operatingCashFlowPerShareTTM	-0.939	2.00	-0.313	-0.626	[0 - 30]
freeCashFlowPerShareTTM	-1.137	2.00	-0.569	-1.137	[0 - 20]
debtEquityRatioTTM	0.345	-1.500	8.62	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.184	1.000	-0.265	-0.265	[0.2 - 0.8]
operatingProfitMarginTTM	-1.072	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.095	1.000	-7.19	-7.19	[0.2 - 2]
assetTurnoverTTM	0.319	0.800	-1.207	-0.966	[0.5 - 2]
Total Score				-3.16

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-3.20	1.000	-0.424	0	[1 - 100]
returnOnEquityTTM	-0.450	2.50	-3.93	-9.16	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.137	2.00	-0.379	-1.137	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.939	2.00	-0.313	-0.626	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0924	1.500	-3.95	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.590	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.75

Prophase Labs Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Prophase Labs Inc

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.